Translational assessment of a DATA-functionalized FAP inhibitor with facile


Journal

European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988

Informations de publication

Date de publication:
09 2023
Historique:
received: 30 01 2023
accepted: 19 05 2023
medline: 5 10 2023
pubmed: 7 6 2023
entrez: 7 6 2023
Statut: ppublish

Résumé

The present study aims at evaluating the preclinical and the clinical performance of [ [ [ The radiochemical, preclinical, and clinical data obtained in this study strongly support further development of [

Identifiants

pubmed: 37284857
doi: 10.1007/s00259-023-06285-2
pii: 10.1007/s00259-023-06285-2
pmc: PMC10541845
doi:

Substances chimiques

Gallium Radioisotopes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3202-3213

Subventions

Organisme : ESKAS
ID : 2021-2022

Informations de copyright

© 2023. The Author(s).

Références

J Nucl Med. 2018 Sep;59(9):1415-1422
pubmed: 29626119
Exp Mol Pathol. 2013 Dec;95(3):350-56
pubmed: 24422232
J Nucl Med. 2018 Sep;59(9):1423-1429
pubmed: 29626120
Eur J Nucl Med Mol Imaging. 2022 Sep;49(11):3651-3667
pubmed: 35608703
Pharmaceuticals (Basel). 2022 Aug 14;15(8):
pubmed: 36015148
J Nucl Med. 2021 Jun 1;62(6):779-786
pubmed: 33097632
Clin Exp Metastasis. 2011 Aug;28(6):567-79
pubmed: 21604185
Front Oncol. 2020 Jul 08;10:979
pubmed: 32733792
Int J Biochem Cell Biol. 2004 Nov;36(11):2320-33
pubmed: 15313476
ChemMedChem. 2015 Jun;10(6):1019-26
pubmed: 25899500
Eur J Nucl Med Mol Imaging. 2021 Mar;48(3):942-944
pubmed: 32783111
Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):1915-1931
pubmed: 33244617
Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):3918-3924
pubmed: 34018010
J Nucl Med. 2013 Jun;54(6):855-60
pubmed: 23516312
Int J Cancer. 2020 Feb 15;146(4):895-905
pubmed: 30734283
Cancer Res. 2002 Aug 15;62(16):4767-72
pubmed: 12183436
Tumour Biol. 2016 Oct;37(10):13961-13971
pubmed: 27492457
J Nucl Med. 2020 Dec;61(12):1806-1813
pubmed: 32332144
J Invest Dermatol. 2003 Feb;120(2):182-8
pubmed: 12542520
Nuklearmedizin. 2021 Oct;60(5):344-354
pubmed: 34256394
Cancer Res. 2010 Sep 1;70(17):6945-56
pubmed: 20699369
Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):721-731
pubmed: 34342669
Cancers (Basel). 2021 Mar 04;13(5):
pubmed: 33806468
J Nucl Med. 2020 Apr;61(4):563-569
pubmed: 31586001
BMC Cancer. 2011 Jun 13;11:245
pubmed: 21668992
Pharmaceuticals (Basel). 2021 Oct 05;14(10):
pubmed: 34681246
J Nucl Med. 2013 Oct;54(10):1755-9
pubmed: 23929824
J Nucl Med. 2022 Jun;63(6):862-868
pubmed: 34556528
Mol Imaging Biol. 2021 Oct;23(5):686-696
pubmed: 33721173
Appl Radiat Isot. 2020 Feb;156:108867
pubmed: 31883763
Eur J Radiol. 2020 Jun;127:109021
pubmed: 32344293
J Nucl Med. 2022 Mar;63(3):415-423
pubmed: 34168013
BMC Cancer. 2020 Oct 27;20(1):1032
pubmed: 33109151
EJNMMI Radiopharm Chem. 2020 Jul 29;5(1):19
pubmed: 32728930
Molecules. 2021 Jun 08;26(12):
pubmed: 34201111
Biomark Res. 2020 Nov 11;8(1):64
pubmed: 33292666
J Nucl Med. 2019 Oct;60(10):1421-1429
pubmed: 30850501
Eur J Nucl Med Mol Imaging. 2021 Dec;49(1):385-389
pubmed: 34226953
Blood. 2006 Feb 15;107(4):1397-404
pubmed: 16223769
Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1611-20
pubmed: 27260521
J Nucl Med. 2020 Aug;61(8):1171-1177
pubmed: 31836685
J Nucl Med. 2019 Mar;60(3):386-392
pubmed: 30072500
Nuklearmedizin. 2020 Sep;59(5):387-389
pubmed: 32392592
EJNMMI Radiopharm Chem. 2019 Jul 25;4(1):16
pubmed: 31659499
J Nucl Med. 2019 Jun;60(6):801-805
pubmed: 30954939
Clin Cancer Res. 2003 May;9(5):1639-47
pubmed: 12738716
J Med Chem. 2014 Apr 10;57(7):3053-74
pubmed: 24617858
Br J Haematol. 2006 Apr;133(1):83-92
pubmed: 16512833
J Nucl Med. 2020 Oct;61(10):1507-1513
pubmed: 32169911

Auteurs

Alondra Escudero-Castellanos (A)

Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Jens Kurth (J)

Department of Nuclear Medicine, Rostock University Medical Centre, Rostock, Germany.

Surachet Imlimthan (S)

Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Elena Menéndez (E)

Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Eirinaios Pilatis (E)

Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Euy Sung Moon (ES)

Department of Chemistry-TRIGA site, Johannes Gutenberg-University of Mainz, Mainz, Germany.

Tilman Läppchen (T)

Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Hendrik Rathke (H)

Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Sarah M Schwarzenböck (SM)

Department of Nuclear Medicine, Rostock University Medical Centre, Rostock, Germany.

Bernd J Krause (BJ)

Department of Nuclear Medicine, Rostock University Medical Centre, Rostock, Germany.

Frank Rösch (F)

Department of Chemistry-TRIGA site, Johannes Gutenberg-University of Mainz, Mainz, Germany.

Axel Rominger (A)

Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Eleni Gourni (E)

Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. eleni.gourni@insel.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH